Sigma Healthcare Limited
SIG
Classificação em ações
#1045
Sigma Healthcare Limited, together with its various operating divisions,... Sigma Healthcare Limited, together with its various operating divisions, primarily engages in the wholesale supply and distribution of pharmaceutical goods across Australia. The company also manages a significant network of approximately 1,200 retail pharmacies, encompassing both independent outlets and prominent brands such as Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave. Beyond retail, its comprehensive service portfolio includes wholesale provisions for hospital pharmacies, as well as crucial dose administration aid services delivered to the aged care sector, community pharmacies, and directly to individuals in their homes. Furthermore, Sigma offers advanced technology solutions and data analytics, alongside product development and support for its range of private and exclusive label products. It is also a key supplier of medical consumables and devices to a broad spectrum of customers, from pharmacies and aged care facilities to hospitals and clinics. In addition, the company provides contract logistics services to pharmaceutical manufacturers and other supply partners. Established in 1912, Sigma Healthcare Limited maintains its corporate headquarters in Rowville, Australia.
Preço da ação
$1.95
Valor de mercado
$22.39B
Variação (1 dia)
-0.18%
Variação (1 ano)
-1.35%
País
AU
Negociar Sigma Healthcare Limited (SIG)
Categoria
Healthcare
Receita da Sigma Healthcare Limited (SIG)
Receita em Jun 2026 TTM: $7.64B
De acordo com os últimos relatórios financeiros da Sigma Healthcare Limited, a receita atual da empresa (TTM) é $7.64B. Em 2024, a empresa obteve uma receita de $2.18B uma diminuição em relação a a receita do ano 2023, que foi de $2.58B. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Sigma Healthcare Limited de 2001 a 2026
Receita no final de cada ano
| Ano | Receita | Alterar |
|---|---|---|
| 2026 (TTM) | $7.64B | 150.36% |
| 2025 | $3.05B | 39.95% |
| 2024 | $2.18B | -15.49% |
| 2023 | $2.58B | 5.96% |
| 2022 | $2.44B | -5.99% |
| 2021 | $2.59B | 19.30% |
| 2020 | $2.17B | -24.90% |
| 2019 | $2.89B | -12.38% |
| 2018 | $3.30B | -0.28% |
| 2017 | $3.31B | 35.12% |
| 2016 | $2.45B | 0.35% |
| 2015 | $2.44B | -6.25% |
| 2014 | $2.60B | -15.90% |
| 2013 | $3.10B | 1.20% |
| 2012 | $3.06B | 4.45% |
| 2011 | $2.93B | 27.32% |
| 2010 | $2.30B | 4.91% |
| 2009 | $2.19B | -18.21% |
| 2008 | $2.68B | 26.67% |
| 2007 | $2.12B | 27.55% |
| 2006 | $1.66B | 531.67% |
| 2004 | $262.65M | 32.71% |
| 2003 | $197.92M | 42.01% |
| 2002 | $139.37M | 98.14% |
| 2001 | $70.34M | 0.00% |
Receita de empresas similares ou concorrentes
| Empresa | Receita | Diferença de Receita | País |
|---|---|---|---|
| $410.98B | 5,278.14% |
US
|
|
| - | - |
US
|
|
| $254.25B | 3,227.10% |
US
|
|
| - | - |
US
|
|
| $13.60B | 78.00% |
US
|
